AbbVie's Dividend Yield Is at Its Lowest Level Since 2018. Here's Why the Stock Is Still a Great Pick for Income Investors Anyway.
A super-high yield isn't everything.
Overview
AbbVie (NYSE: ABBV) has been a favorite for income investors since spinning off from Abbott Labs (NYSE: ABT) in 2013. For much of the past 13 years, the big drugmaker offered one of the more attractive dividend yields in the healthcare sector.
However, AbbVie's dividend yield today hovers around 2.6% -- the lowest level since early 2018. For investors accustomed to collecting yields of 3.5% or more, this relatively smaller amount might not seem appealing. But there's a good case to be made that AbbVie is still a great pick for income investors anyway.
Image source: Getty Images.
Details
Source
Originally published at www.fool.com.
Related Articles
- Prediction: This Is How Much Micron Stock Will Be Worth By the End of 2027
- Solana ETFs Just Set a New Record With $188 Million in Weekly Inflows. Here's Why I'm Bullish on Solana for 2027.
- Stocks Are Expensive and Investors Are Getting Scared. Warren Buffett's 13-Word Rule Has Specific Advice for Both Conditions.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.